Barinthus Biotherapeutics Plc. - ADR

NASDAQ:BRNS   12:04:43 AM EDT
1.26
0.00 (+0.09%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Barinthus Biotherapeutics Plc. - ADR Stock, NASDAQ:BRNS

Zeus Building, Rutherford Avenue, Didcot, Oxfordshire OX11 0DF
United Kingdom
Phone: +44.18.6581.8808
Number of Employees: 130

Description

Barinthus Biotherapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of antigen-specific immunotherapeutics that induce T cells to treat chronic viral infections, autoimmune diseases, and cancer. It also focuses on the pipeline of both clinical and preclinical stage therapeutic, and prophylactic programs. The company was founded by Adrian Hill and Dame Sarah Gilbert in March 2021 and is headquartered in Didcot, the United Kingdom.